Globe Artichoke

Materia Medica

Globe Artichoke

Cynara scolymus

Globe artichoke (Cynara scolymus) — a bitter liver and gallbladder tonic used for high cholesterol, metabolic syndrome and healthy digestion.

What Is Artichoke?

Originating from the Mediterranean, globe artichokes have since spread the world over. They’re used as both food and medicine.

The unopened flowering bracts are harvested and eaten as a delicacy, while the leaves are mainly used as a bitter, and treatment for liver and gallbladder conditions.

The bitter principles stimulate the release of bile from the gallbladder, and cynarin, one of the main bioactive compounds in the plant protects the liver from metabolic dysfunction.

What Is Artichoke Used For?

Globe artichoke is mainly used for metabolic syndrome, diabetes, high cholesterol or hypertriglyceridemia. It’s also used as a digestive supportive, liver supportive, cardiosupportive, gallbladder deficiencies, and allergies.

Botanical Information

Artichoke is part of the asteraceae (sunflower) family of plants, which is the largest of the flowering species of plants.

The Cynara genus consists of about 10 species. The main species used as medicine is Cynara scolymus, however, many of the other species are eaten as a vegetable.

Globe artichoke is a type of thistle, characterized by sharp prickles on the leaf margins. Other members of the family include Milk Thistle (Silybum marianum), and Scotch thistle.

Habitat, Ecology & Distribution

Globe artichoke originated in the Mediterranean basin, and was known well by the ancient Romans, and Greeks 6Reference 6Roberta Dosi et al. · 2013Nutritional and metabolic profiling of the globe artichoke (Cynara scolymus L. ‘Capuanella’ heads) in province of Caserta, Italy.

Pharmacology & Medical Research

Cholesterol

A group of European scientists in the 1970s was the first to document Cynarins cholesterol-lowering effect on humans 7Reference 7Taylor · 2005The healing power of rainforest herbs: A guide to understanding and using herbal medicinals. Since then, many articles and studies have been produced examining the effects cynarin has on the liver and cholesterol in both humans and animals. During this time, scientists have discovered that cynarin is not the only constituent in artichoke to produce these effects, with several of them just newly discovered.

The cholesterol-lowering effects were reported to be due to an inhibitory effect on hepatocytes associated with de novo cholesterol biosynthesis. The constituent suggested to be responsible for this action is known as luteolin (inhibits 30-80%). Secondly, the choleretic activity of C. scolymus increases the excretion of cholesterol through bile. This was confirmed in vivo when a randomized, double-blind, placebo-controlled group study showed a significant decrease in LDL, with an increase in HDL compared to the treatment group 5Reference 5K · 1997Artichoke leaf extract - Recent findings reflecting effects on lipid metabolism, liver and gastrointestinal tracts.

Diabetes

The chlorogenic acid content produces the ability to regulate glucose levels in the blood through the inhibition of the glucose- 6-phosphatase 6Reference 6Roberta Dosi et al. · 2013Nutritional and metabolic profiling of the globe artichoke (Cynara scolymus L. ‘Capuanella’ heads) in province of Caserta, Italy.

Antioxidant

Various studies have been conducted on C. scolymus’ antioxidant effects. Taylor L. (2005) refers to 2 studies: one in 2002 focused on the antioxidant properties in cultured blood vessel cells and noted marked protection against oxidative stress induced by inflammatory mediators. She lists another study, done in 2000 that focused on human white blood cells under various forms of oxidative stress that lists results consistent with these findings.

G. Sonnante et al., (2010), reports that much of the antioxidant effects are due to the polyphenol content (flavonoids, and phenolic acids), particularly chlorogenic acid, di-caffeoylquinic acids, and caffeic acid. These chemicals are contained in high amount in the flowering bracts.

Choleretic

One study showed that Cynara scolymus leaf extract significantly increased bile secretion into the duodenum of healthy volunteers 5Reference 5K · 1997Artichoke leaf extract - Recent findings reflecting effects on lipid metabolism, liver and gastrointestinal tracts. These effects are likely the cause of globe artichoke’s positive effects on dyspepsia symptoms.

Digestion

Indigestion (dyspepsia), is one of the most prevalent symptoms in the western world. There are many possible causes for this condition, including biliary dyskinesia, insufficient secretion of digestive enzymes and hydrochloric acid, diet content, gut flora (ex: H. pylori), pharmaceutical side effects (NSAIDs), and various psychological factors. C. scolymus has been shown to improve the symptoms of dyspepsia and produced suggestively corrective support for the condition 4Reference 4G et al. · 2002Artichoke leaf extract reduces mild dyspepsia in an open study.

Hepatoprotective

Taylor L. (2005) refers to a study in her book done in 2002, which noted that artichoke leaf extract was able to reverse the damage done in rat liver cells by harmful chemicals — as a result, the extract was able to enhance bile production.

Metabolic Syndrome

Defined by a set of different metabolic disorders including obesity, hyperglycemia, atherogenic dyslipidemia, and hypertension. This disease process increases the chances of developing type-2 diabetes, and cardiovascular disease significantly. Some research suggests that this syndrome is experienced by 20-30% of the adult population. The causative factors associated with this disease process are obesity, poor nutrition, and physical inactivity.

Some other studies have shown that uric acid may have a pathogenic role in the process of metabolic syndrome, and this relationship was demonstrated in rats. Inhibition of xanthine oxidase will lower uric acid levels, and decrease oxidative stress associated with it 1Reference 1A et al. · 2015In vitroIn vitro inhibitory potential of Cynara scolymus, Silybum marianum, Taraxacum officinale, and Peumus boldus on key enzymes relevant to metabolic syndrome.

Blood pressure regulation is mostly reliant on angiotensin-converting enzyme (ACE), which converts angiotensin 1, into the powerfully vasoconstricting angiotensin 2. Therefore, inhibition of ACE is one of the main modes of actions used to control the hypertension aspect of metabolic syndrome 1Reference 1A et al. · 2015In vitroIn vitro inhibitory potential of Cynara scolymus, Silybum marianum, Taraxacum officinale, and Peumus boldus on key enzymes relevant to metabolic syndrome.

One route for the treatment of type 2 diabetes mellitus, would be to use agents that will reduce postprandial hyperglycemia, by inhibiting carbohydrate digesting enzymes, such as ⍺-glucosidase 1Reference 1A et al. · 2015In vitroIn vitro inhibitory potential of Cynara scolymus, Silybum marianum, Taraxacum officinale, and Peumus boldus on key enzymes relevant to metabolic syndrome.

Boldacynara® contains herbs that have been shown as single extracts, to produce a variety of effects, positively affecting metabolic syndrome abnormalities. These herbs include Cynara scolymus, Taraxacum officinale, Silybum marianum, and Peumus boldus. In a study investigating the effects of this formula, by looking closer at the impact of the single extracts included, found that C. scolymus was able to provide ACE inhibition, and pancreatic lipase inhibition 1Reference 1A et al. · 2015In vitroIn vitro inhibitory potential of Cynara scolymus, Silybum marianum, Taraxacum officinale, and Peumus boldus on key enzymes relevant to metabolic syndrome. These effects are likely due to the polyphenol content, which is known to have a strong affinity for proteins.

Phytochemistry

The bitter taste of Cynara scolymus and most of its liver activity trace to its caffeoylquinic acids — above all cynarin (1,5-di-O-caffeoylquinic acid) and chlorogenic acid — concentrated in the green parts of the plant, with the highest levels in the leaves 7Reference 7Taylor · 2005The healing power of rainforest herbs: A guide to understanding and using herbal medicinals. Cynarin is considered one of the plant’s principal biologically active constituents.

The characteristic bitterness is carried chiefly by the sesquiterpene lactone cynaropicrin, while the antioxidant and choleretic actions are reinforced by flavonoids such as luteolin and its glycoside scolymoside. Dried leaf is standardised on its phenolics: pharmacopoeial material should carry not less than ~0.8% chlorogenic acid, total mono-caffeoylquinic acids run roughly 0.5–4%, and commercial extracts are commonly set to 2.5–5% cynarin or 5–20% total caffeoylquinic acids 7Reference 7Taylor · 2005The healing power of rainforest herbs: A guide to understanding and using herbal medicinals. Taylor (2005) additionally records caffeic acid, ferulic acid, inulin, cyanidol glucosides, the triterpene alcohols pseudotaraxasterol and taraxasterol, and a range of fatty acids 7Reference 7Taylor · 2005The healing power of rainforest herbs: A guide to understanding and using herbal medicinals.

The fleshy flowering heads are also a rich source of nutrition: the cultivar ‘Capuanella’, for example, contains protein (3.08 g/100 g), amino acids (2.83 g/100 g, mainly asparagine), linoleic acid (44.20% of total fatty acids), and total phenols (425.46 mg/100 g) 6Reference 6Roberta Dosi et al. · 2013Nutritional and metabolic profiling of the globe artichoke (Cynara scolymus L. ‘Capuanella’ heads) in province of Caserta, Italy. The majority of artichoke’s remedial actions are believed to be due to its polyphenolic antioxidants and high nutrient density 6Reference 6Roberta Dosi et al. · 2013Nutritional and metabolic profiling of the globe artichoke (Cynara scolymus L. ‘Capuanella’ heads) in province of Caserta, Italy.

Constituent Summary

Phenolic figures refer to dried leaf (% dry weight) or, where noted, to standardised extracts; head/fatty-acid figures are for fresh flowering heads. Values vary widely with cultivar, tissue and growing conditions. “No Data” marks constituents recorded in the plant but without a reliable published figure.

Grouped by class · 20 compounds
Phenolic Acid7 compounds3 with data
Phenolic AcidCynarin~2.5–5% (standardised extract)
Phenolic AcidChlorogenic acid≥~0.8% (dry leaf)
Phenolic AcidCaffeoylquinic acids~0.5–4% (dry leaf)
Phenolic AcidDi-caffeoylquinic acidsNo data
Phenolic AcidCaffeic acidNo data
Phenolic AcidNeochlorogenic acidNo data
Phenolic AcidFerulic acidNo data
Sesquiterpene Lactone2 compoundsno data
Sesquiterpene LactoneCynaropicrinNo data
Sesquiterpene LactoneCynaratriolNo data
Flavonoid4 compounds1 with data
FlavonoidLuteolinNo data
FlavonoidScolymosideNo data
FlavonoidLuteolin glucosidesNo data
FlavonoidTotal flavonoids~0.1–1%
Anthocyanin1 compoundno data
AnthocyaninCyanidol glucosidesNo data
Fructan1 compoundno data
FructanInulinNo data
Triterpene2 compoundsno data
TriterpenePseudotaraxasterolNo data
TriterpeneTaraxasterolNo data
Sterol2 compoundsno data
SterolBeta-sitosterolNo data
SterolStigmasterolNo data
Fatty Acid1 compound1 with data
Fatty AcidLinoleic acid~44% of total fatty acids (heads)

Clinical Applications

The combination of ACE inhibitor, glucose-6-phosphatase inhibition, choleretic, and antioxidant value of artichoke makes it especially useful for conditions related to metabolic syndrome (diabetes, hypercholesterolemia, hypertriglyceridemia, and cardiovascular disease). Additionally, artichoke is useful for reducing toxic burden, and relieving dyspepsia.

Cautions & Safety

Avoid strong concentrations if pregnant (normal dosage range is okay), or if gallstones are present, the cholagogue activities of this herb can force the stones to block the gall ducts.

Synergy

A herbal formula, Boldocynara®, containing Cynara scolymus, Silybum marianum, Taraxacum officinale, and Peumus boldus, has been shown to produce positive effects on the abnormalities associated with metabolic syndrome 1Reference 1A et al. · 2015In vitroIn vitro inhibitory potential of Cynara scolymus, Silybum marianum, Taraxacum officinale, and Peumus boldus on key enzymes relevant to metabolic syndrome.

References

  1. A. Villiger, F. Sala, A. Suter, V. Butterweck. (2015). In vitro inhibitory potential of Cynara scolymus, Silybum marianum, Taraxacum officinale, and Peumus boldus on key enzymes relevant to metabolic syndrome. Phytomedicine. Vol 22. 138-144.
  2. Gabriella Sonnante*, Rosalinda D’Amore, Emanuela Blanco, Ciro L. Pierri, Monica De Palma, Jie Luo, Marina Tucci, and Cathie Martin. (2010). Novel Hydroxycinnamoyl-Coenzyme A Quinate Transferase Genes from Artichoke Are Involved in the Synthesis of Chlorogenic Acid. Plant Physiology. Vol. 153, pp. 1224–1238
  3. G.C Dong, P.H Chuang, K.C Chang, P.S. Jan, P.I Hwang, H.B. Wu, M. Yi, H.X Zhou, H.M. Chen. (2008). Blocking effect of an immunosuppressive agent, Cynarin, on CD28 of T-cell receptor. Pharmaceutical Research. Vol 26. 2.
  4. G. Marakis, A. F. Walker, R. W. Middleton, J. C. L. Booth3, J. Wright, and D. J. Pike. (2002). Artichoke leaf extract reduces mild dyspepsia in an open study. Phytomedicine. Vol 9: 694–699
  5. K. Kraft. (1997). Artichoke leaf extract - Recent findings reflecting effects on lipid metabolism, liver and gastrointestinal tracts. Phytomedicine. Vol 4. 4. 369-378.
  6. Roberta Dosi, Addolorata Daniele, Vincenzo Guida, Luigia Ferrara, Valeria Severino, Antimo Di Maro. (2013). Nutritional and metabolic profiling of the globe artichoke (Cynara scolymus L. ‘Capuanella’ heads) in province of Caserta, Italy. Australian Journal of Crop Science. Vol 17. 12. 1923-1934.
  7. Taylor, L. (2005). The healing power of rainforest herbs: A guide to understanding and using herbal medicinals. Garden City Park, NY: Square One Publishers.